BEN-MAIMON CAROLE 4
4 · Larimar Therapeutics, Inc. · Filed Jun 30, 2020
Insider Transaction Report
Form 4
BEN-MAIMON CAROLE
DirectorPresident and CEO
Transactions
- Other
Common Stock
2020-06-26+25,083→ 25,083 total
Footnotes (1)
- [F1]Pro rata distribution from Chondrial Therapeutics Holdings, LLC ("Holdings") to its members, for no consideration. The reporting person is a member of the board of managers and President and Chief Executive Officer of Holdings.